Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments to CMS about Proposed Decision for Medicare Coverage of NGS for Advanced Cancer
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
ACMG & ASHG Presidents’ Sign-on Letter to Congress Concerning Patent Eligibility Reform
-
Group Sign-on Letter to Congress Opposing Proposed Amendments to Section 101 of the Patent Act
-
ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427